Interleukin 5 (IL5) acts on eosinophil differentiation and activation, suggesting the existence of a membrane receptor for IL5 on eosinophils. Here, we report that 125 1-labeled recombinant human 11,5 bound, at 4°C, to high affinity receptors on human eosinophils. The association constant was higher for hypodense eosinophils (1.93 x 109 M-1) than for normodense cells (0.39 x 109 M -1), with a closely related number of receptor sites per cell. No specific binding occurred on neutrophils. The specific binding of 1165 was induced by overnight incubation at 37°C of human eosinophils with granulocyte/macrophage (GM)-CSF. The levels of increase were significantly higher for normodense than for hypodense eosinophils, suggesting a previous in vivo activation of the later subpopulation by GM-CSF 1173 was ineffective by itself but synergistically enhanced the effect of GM-CSF. Specificity studies showed that the binding of 125 1-labeled IL5 was inhibited by 116, but not by other cytokines, on human eosinophils. These results show the existence of a specific binding site for IL5 on human eosinophils with a variable affinity on eosinophil hypodense or normodense subpopulations, as previously reported for other membrane receptors .
Summary
Interleukin 5 (IL5) acts on eosinophil differentiation and activation, suggesting the existence of a membrane receptor for IL5 on eosinophils. Here, we report that 125 1-labeled recombinant human 11,5 bound, at 4°C, to high affinity receptors on human eosinophils. The association constant was higher for hypodense eosinophils (1.93 x 109 M-1) than for normodense cells (0.39 x 109 M -1), with a closely related number of receptor sites per cell. No specific binding occurred on neutrophils. The specific binding of 1165 was induced by overnight incubation at 37°C of human eosinophils with granulocyte/macrophage (GM)-CSF. The levels of increase were significantly higher for normodense than for hypodense eosinophils, suggesting a previous in vivo activation of the later subpopulation by GM-CSF 1173 was ineffective by itself but synergistically enhanced the effect of GM-CSF. Specificity studies showed that the binding of 125 1-labeled IL5 was inhibited by 116, but not by other cytokines, on human eosinophils. These results show the existence of a specific binding site for IL5 on human eosinophils with a variable affinity on eosinophil hypodense or normodense subpopulations, as previously reported for other membrane receptors .
T he production and differentiation of eosinophils are thought to be controlled by a group of hemopoietic growth factors, namely, IL-3, granulocyte/macrophage CSF (GM-CSF),' and IL-5 (1-3). However, 1175 appears to be selective for the eosinophil lineage and stimulates the production and maturation of eosinophils at terminal stages (1) (2) (3) . Human eosinophil heterogeneity is characterized by the existence during hypereosinophilic diseases of a subpopulation of eosinophils called "hypodense" (4-7). Hypodense eosinophils can be distinguished by an impaired oxidative metabolism (6) and by an increased cytotoxic potential against parasitic targets in vitro (7) . Moreover, these cells exhibit an increased expression of various membrane receptors (5, 7, 8) besides a variability in protein expression (9) . The presence of hypodense eosinophils in hypereosinophilic situations can therefore be related to eosinophils in a state of activation, in addition to increased eosinophilopoiesis. IL5 might represent the major cytokine involved in the induction ofhypodense eosinophils and therefore in eosinophil-mediated pathology ' Abbreviations used in this paper. CR3, complement receptor type 3; GM-CSF, granulocyte/macropbage colony stimulating factor; K,, association constant ; rh, recombinant human . 1347 (4) . Similarly to other lymphokines, the biological effects of IL5 are probably linked to the interaction with specific receptors on susceptible targets . However, despite numerous studies on IL5, nothing is known about the binding capacity of IL5 to human eosinophils. The aim of the present study was to demonstrate the existence of a specific receptor for recombinant human (rh) IL5 on human eosinophils and to investigate the variation of its expression in relation to eosinophil heterogeneity. The effects of IL-3 and GM-CSF were evaluated on IL5-specific binding to human eosinophils.
Materials and Methods
Reagents. Purified rb 11,5 was obtained as described elsewhere (10) . rh 11, 3 and rh GM-CSF were generous gifts from Sandoz, Ltd . (Basel, Switzerland) and Dr. R. L. Coffman (DNAX Institute, Palo Alto, CA), respectively. rh IFN-.y was provided by Roussel-Uclaf (Romainville, France) .
Purification ofEosinophih Human eosinophils were purified from the venous blood ofpatients with hypereosinophilia bycentrifugation upon discontinuous 18-25% (wt/vol) metrizamide gradients (Nyegaard Co., Oslo, Norway) according to the technique previously described (6, 7) . Several cell fractions containing >85% pure eosinophils (range of purity 85-99.7%) were collected from the gradients. Eosinophils obtained in the lower density layers corresponding to 20-22% metrizamide were referred to as hypodense eosinophils. Eosinophils collected from the 23-25% metrizamide layers were referred to as normodense eosinophils (6, 7) . Neutrophils purified from normal volunteers by centrifugation on metrizamide gradients were always >95% pure, with no contaminating eosinophils.
Cell Culture Conditions. Freshly isolated eosinophils in RPMI 1640 supplemented with 10% FCS and antibiotics were incubated in the presence or absence of rh GM-CSF (5 x 10 -'o M) and/or rh 11,3 (2 x 10 -10 M) overnight at 370C in 5% C02. After overnight incubation, eosinophils were used for IM binding assay, in comparison with freshly isolated human eosinophils .
Radiolabeling ofrh IL5. rh IL5 was radiolabeled by the Iodogen (Pierce Chemical Co., Rockford, IL) method yielding to a high specific activity with little to no reduction in biological activity, as previously described (11) . Briefly, 2 ug of rh IL5 dissolved in 20 ul PBS was added to a microfuge tube coated with 5 j ug of dried Iodogen and containing 10 Ag of PBS with 500 uCi 125I-Na (Amersham International, Amersham, UK) . The mixture was incubated at 40C for 20 min. Radiolabeled rh 11,5 was separated from excess 125 1 by using a gel filtration column (model PD-10; Pharmacia Fine Chemicals, Piscataway, NJ). The average specific radioactivity was 1.82 t 0.41 x 10'5 cpm/mmol .
Binding Assay for '24-labeled rh 11,5. The binding of 125 1-labeled rh IM was measured according to the method described previously (11, 12) with some modifications . Briefly, before addition of various concentrations of 1251-IIr5, the cells (106 in 100 Al HBSS with 0.35% BSA and 0.0025% cycloheximide) were incubated in the presence or absence of a 100-fold excess of unlabeled rh IIr5 for 30 min at 4°C. After incubation, serial dilutions of radiolabeled rh IL5 were added and the cells were incubated in microfuge tubes at 4°C for 2 h. After washings, the cell suspensions were centrifuged at 8,500 g for 2 min, through 1 ml of 20% sucrose, and the radioactivity ofthe pellets was measured in a gamma counter (LKB, Turku, Finland). Each experiment was performed in duplicate or more. The specific binding was defined as the difference between the total binding and the nonspecific binding obtained in the presence ofa 100-fold molar excess ofunlabeled rh IM. The association constant (K,) and the average number of binding sites per cell were calculated by Scatchard analysis of the saturation binding data.
Statistical Analysis. Data were expressed as mean ± SE. Student's t test was used for comparison of means, a P value of 0.05 or less being considered significant .
Results
Binding Characteristics ofIL5 on Eosinophils. A saturation binding experiment with eosinophils using 106 cells per point was performed at 4OC for 2 h in the presence of increasing concentrations of 125 1-IL5. As shown in Fig. 1 , 1251-11,5 specifically bound to human eosinophils and reached saturation at an approximate concentration of 1.0 or 1.25 nM. In this representative experiment, the specific binding of rh IL5 to normodense and to hypodense eosinophils obtained from the same patient was compared . Scatchard plot analysis of the binding data revealed the presence of 600 receptors per cell with an apparent K, of 1.0 x 109 M -1 on hypodense eosinophils and 490 receptors per cell with a K, of 3.7 x 108 M -1 on normodense eosinophils (Fig. 1, inset) . To The binding of rh IL5 was evaluated on neutrophils . No significant difference between total and nonspecific binding was observed, indicating that specific IL5Rs were not detectable on human neutrophils (data not shown) .
Induction ofIL5R on Human Eosinophils. To further investigate the mechanisms involved in the heterogeneous expression of IL5R, human eosinophils were cultured overnight in the presence or absence of GM-CSF or IL3 before the IM binding assay. Results shown in Fig. 2 indicated that IL5 binding to hypodense eosinophils could be modulated after in vitro incubation with GM-CSF. Whereas eosinophils cultured without GM-CSF expressed a low specific IL-5 binding, the specific 11,5 binding was increased when the same eosinophils had been cultured with GM-CSF. The Scatchard analysis revealed in the later case the existence of 550 receptors per cell with a K, of 2.87 x 109 M -1 ( Each point represents the mean of duplicate determinations . In this study, hypodense eosinophils were used.
2, inset) . In addition, when human eosinophils first cultured without GM-CSF were then cultured with GM-CSF overnight, a specific binding of 11,5 was now expressed . The Scatchard analysis revealed the existence of 210 receptors per cell with a K, of 3.2 x 109 M-1 (Fig. 2, inset ) . In the same conditions, human eosinophils cultured with IL-3 did not specifically bind 11,5 similarly to eosinophils cultured without lymphokines (data not shown) . To extend these findings, the specific IL-5 binding was evaluated on normodense and hypodense eosinophils cultured overnight in the presence or absence of GM-CSF before incubation with 125 1-IL5 (Fig.  3 A) . As previously shown, in the case of freshly isolated eosinophils (preculture conditions), the specific IL-5 binding was greater on hypodense than on normodense eosinophils. After culture without GM-CSF (medium alone), the specific IL-5 binding was still detected on hypodense eosinophils, but not on normodense eosinophils. However, cultivation with GM-CSF induced 116-specific binding both on hypodense or normodense eosinophils. It can be also noticed on Fig.  3 A that the increasing effects of GM-CSF, when compared with precultured eosinophils, were significantly higher in the case of normodense than in the case of hypodense eosinophils.
1349
Chihara et al. Results presented in Fig. 3 B revealed that IL3 could not by itself induce the specific binding of 11,5. However, when eosinophils were cultured with GM-CSF and IL3 together an increase in the specific IL-5 binding to eosinophils was detected, suggesting a synergistic effect between IL-3 and GM-CSF. Specificity of11,5 Binding to Human Eosinophils. To determine whether the binding of IL5 to human eosinophils was specific for IM, competition binding experiments with other lymphokines showing amino acid sequence homology with IL5 in short segments were performed . None of the lymphokines tested -IL3 (5 x 10 -6 M), GM-CSF (5 x 10 -6 M), and IFN-y (1 x 10 -6 M)-showed any significant effect on the binding of 1251-IL5 to human eosinophils (data not shown) .
Discussion
IL5 plays a major role in the production, differentiation, and activation of eosinophils as well as B lymphocytes (12) . The pleiotropic effects of IM on hematopoietic cells are probably linked to the expression of specific receptors on susceptible target cells . However, despite the well-known biological effects of IL5, there is no report on a specific binding site for IL5 on eosinophils, while a recent study described an ILSR on a murine B cell line (12) . In the present paper, and to examine the level of expression of a receptor for 11,5 on human eosinophils . The results presented here show that 11,5 specifically interacts on the surface of eosinophils but not on neutrophils, a finding that correlates with the lack of effect of 11,5 on the neutrophil myeloid series . The present results indicate that the binding of 11,5 was to a single class affinity receptor. This is similar to receptors for 11,3 or GM-CSF on human eosinophils (13) , but different from the receptor for IL-5 described on the murine B cell line BCL1-B20 (12) . From the Scatchard plot analyses, IL5R expression was different on hypodense and normodense eosinophils. 11,5 bound to hypodense eosinophils with a fivefold higher K, than for normodense eosinophils, a result that suggests the previous in vivo activation of hypodense eosinophils. In contrast, the number of receptor sites per cell was not different between the two eosinophil cell populations, and was consistent with the small number of high affinity receptors for other lymphokines (IL3 and GM-CSF) recently described on eosinophils (13) . After an overnight incubation ofeosinophils at 37°C, in the absence of added cytokines, a specific binding of labeled 11,5 was still detected on hypodense eosinophils but not on normodense populations . These results might indicate that the loss o£ binding capacity of IL5 was slower for hypodense than for normodense eosinophils. This is consistent with the fact that hypodense eosinophils have a prolonged life span in vivo and ex vivo without lymphokines (4, 5) . Our results on IL5 binding to hypodense and normodense eosinophils further illustrate the heterogeneity of these two populations already demonstrated for the expression of low-affinity IgE receptors and IgE-mediated cytotoxic function, and the expression ofCR3 (7, 8) as well as protein profiles (9) . These similarities suggest that the biological changes in hypodense eosinophils might be under the influence of the same factors. In fact, in a different study related to the induction of various surface markers on eosinophils, we could recently show that the expression of CD23, CD11b (CR3), and CD4 was closely related to the effect of eosinophilopoietic growth factors such as 11,5 (Chihara, J., V Gruart, J. Plumas, A. Capron, and M. Capron, manuscript in preparation).
In the context ofthe variable expression of IL5Rs on human eosinophils, it was interesting to investigate the effects ofeosinophilopoietic growth factors such as GM-CSF and IIs3 on the specific IL5 binding. The present results indicate that an overnight culture with GM-CSF could increase the expression of IL5R not only on hypodense, but also on normodense eosinophils. The level of increase of IL5 binding after induction by GM-CSF was inferior for hypodense than for normodense eosinophils, suggesting that hypodense eosinophils might have been exposed to an excess of GM-CSF in vivo, and might be deactivated upon further exposure. The enhancing effects of GM-CSF on IL5 binding to human eosinophils are consistent with the ability of this factor to stimulate eosinophil colonies in vitro. Indeed, eosinophil colonies are selectively induced by 116, but further enhanced after the addition of GM-CSF or IL3 (1, 3) . In fact, IL-3 alone could not induce IL5 binding to human eosinophils. However, in synergy with GM-CSF, IL3 could increase 11,5 binding to human eosinophils. These findings are not in total agreement with a recent study showing a reciprocal inhibition of binding to human eosinophils between IL-3 and GM-CSF and suggesting common biological effects (13) . In our studies, the binding or radiolabeled 11,5 to eosinophils was found to be inhibited only by unlabeled 11,5 and not by 11,3, GM-CSF, IFN-y suggesting the specificity of the binding site for IL5 on human eosinophils . The characteristics of IL-5 binding to human eosinophils and to murine B cells are not totally identical, especially with respect to the presence of a single class affinity receptor for eosinophils, whereas high-and lowaffinity receptors are detected on B cell lines (12) . Furthermore, mAbs to mouse B cell IL5Rs did not bind to human eosinophils (data not shown) . Because ofthe limited amount of eosinophils from human patients, only preliminary crosslinking studies have been performed. They suggest that the IL5R on human eosinophils has an approximate molecular weight of 50,000. The molecular relationships between the IL5R on eosinophils and on B lymphocytes await further investigation .
